SUDARSCHEM Sudarshan Chemical Industries Q4 FY26 results (Jan–Mar 2026) and concall
Sudarshan Chemical Industries reported a strong Q4 FY26, with the acquired Heubach group outperforming EBITDA expectations and significant inventory reduction. The company's net debt decreased, and the RIECO business achieved positive EBITDA and strong revenue growth. However, the company is navigating challenges from geopolitical tensions, which have led to increased raw material, energy, and logistics costs, while the legacy business saw flattish revenue due to strategic adjustments.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 106.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 696 | 666 | 1,349 | 2,507 | 2,387 +243% | 2,103 +216% | 2,790 +107% |
| EBITDA | 94 | 79 | 127 | 192 | 132 +40% | 38 −52% | 227 +79% |
| Net profit | 30 | 1 | 0 | 55 | 19 −37% | -116 −11700% | 82 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





